Recent advances in aromatase inhibitor therapy for breast cancer

被引：14

作者：

Assikis, VJ

Buzdar, A

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Div Breast Med Oncol, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.34064

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：120 / 128

页数：9

共 46 条

[41] SUPPRESSION OF RESIDUAL ESTROGEN PRODUCTION WITH AMINOGLUTETHIMIDE IN WOMEN FOLLOWING SURGICAL HYPOPHYSECTOMY OR ADRENALECTOMY [J].

SAMOJLIK, E ;

SANTEN, RJ ;

WORGUL, TJ .

CLINICAL ENDOCRINOLOGY, 1984, 20 (01) :43-51

[42] RESISTANCE OF THE OVARY TO BLOCKADE OF AROMATIZATION WITH AMINOGLUTETHIMIDE [J].

SANTEN, RJ ;

SAMOJLIK, E ;

WELLS, SA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (03) :473-477

[43] TAMOXIFEN VERSUS AMINOGLUTETHIMIDE IN ADVANCED BREAST-CARCINOMA - A RANDOMIZED CROSSOVER TRIAL [J].

SMITH, IE ;

HARRIS, AL ;

MORGAN, M ;

FORD, HT ;

GAZET, JC ;

HARMER, C ;

WHITE, H ;

PARSONS, CA ;

VILLARDO, A ;

WALSH, G ;

MCKINNA, JA .

BRITISH MEDICAL JOURNAL, 1981, 283 (6304) :1432-1434

[44]

Tekmal RR, 1996, CANCER RES, V56, P3180

[45] Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study [J].

Thurlimann, B ;

Paridaens, R ;

Serin, D ;

Bonneterre, J ;

Roche, H ;

Murray, R ;

diSalle, E ;

Lanzalone, S ;

Zurlo, MG ;

Piscitelli, G .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1767-1773

[46] Arimidex (ZD1033): A selective, potent inhibitor of aromatase in postmenopausal female volunteers [J].

Yates, RA ;

Dowsett, M ;

Fisher, GV ;

Selen, A ;

Wyld, PJ .

BRITISH JOURNAL OF CANCER, 1996, 73 (04) :543-548

← 1 2 3 4 5 →